AstraZeneca PLC (AZN)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 07, 2025

$134.16

P/E Ratio

32.43

Market Cap

$208.85B

Loading...
Description

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Metrics

Overview

  • HQCambridge, CA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerAZN
  • Price$134.159991+0.35%

Trading Information

  • Market cap$208.85B
  • Float94.76%
  • Average Daily Volume (1m)1,218,796
  • Average Daily Volume (3m)1,620,364
  • EPS$3.30

Company

  • Revenue$40.38B
  • Rev growth (1yr)14.90%
  • Net income$1.10B
  • Gross margin71.08%
  • EBITDA margin33.93%
  • EBITDA$3.54B
  • EV$200.92B
  • EV/Revenue4.98
  • P/E32.43
  • P/S4.14
  • P/B5.47
Documents
Factset Street Account